AcelRx Pharmaceuticals, Inc. Short Interest Up 14.6 percent in August
ACRXDelisted Stock | USD 1.01 0.01 1.00% |
Slightly above 50% of AcelRx Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in AcelRx Pharmaceuticals suggests that some traders are interested regarding AcelRx Pharmaceuticals' prospects. AcelRx Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, AcelRx Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
AcelRx |
AcelRx Pharmaceuticals, Inc. saw a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 1,180,000 shares, an increase of 14.6 percent from the July 31st total of 1,030,000 shares. Approximately 7.6 percent of the shares of the company are sold short. Based
Read at thelincolnianonline.com
AcelRx Pharmaceuticals Fundamental Analysis
We analyze AcelRx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AcelRx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AcelRx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Earning
Price To Earning Comparative Analysis
AcelRx Pharmaceuticals is currently under evaluation in price to earning category among its peers. Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
AcelRx Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AcelRx Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of AcelRx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing AcelRx Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
AcelRx Pharmaceuticals Related Equities
ASRT | Assertio Therapeutics | 4.06 | ||||
LFCR | Lifecore Biomedical | 2.93 | ||||
AMRX | Amneal Pharmaceuticals, | 1.29 | ||||
TLRY | Tilray | 0.88 | ||||
ORGO | Organogenesis Holdings | 0.85 | ||||
AQST | Aquestive Therapeutics | 1.60 | ||||
EVOK | Evoke Pharma | 2.65 | ||||
SHPH | Shuttle Pharmaceuticals | 3.26 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in AcelRx Stock
If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |